MYO-PLUS | Myostatin & Anabolic Research Formula
Overview
MYO-PLUS by Atom Human Research is a research-grade formulation combining YK-11 and MK-2866 (Ostarine). This dual-compound system is engineered for controlled laboratory studies focused on the interaction between selective androgen receptor modulators and myostatin pathway inhibitors in biological models.
Key Features
Dual-Compound Synergy – Combines a myostatin-modulating compound (YK-11) with an androgen receptor modulator (MK-2866) for advanced anabolic and musculoskeletal investigations.
Verified Purity – Each batch undergoes independent HPLC testing confirming 99%+ purity.
Research-Only Use – Developed exclusively for qualified laboratory environments conducting in vitro and in vivo studies.
Precision Formulation – Designed for reproducibility, consistency, and analytical reliability across experimental conditions.
Research Focus
MYO-PLUS is commonly examined in studies involving:
Mechanistic analysis of myostatin inhibition and muscle differentiation markers
Evaluation of androgen receptor–mediated protein synthesis
Comparative studies on muscle regeneration, cell growth, and anabolic gene expression
Assessment of bone density, tissue recovery, and metabolic signaling pathways
These research areas are based on independent third-party studies and do not imply performance or efficacy in humans.
Buyer Responsibility
By purchasing MYO-PLUS, the buyer affirms they are a qualified professional authorized to handle experimental materials. The buyer assumes full responsibility for compliance with all applicable laws, laboratory safety standards, and research protocols. Atom Human Research is not liable for any misuse, mishandling, or unlawful application of this material.
🔬 Research Use Only
This formulation contains experimental compounds intended strictly for laboratory and investigative use. It is not approved for human consumption or medical application. All buyers must adhere to relevant laws, ethical research practices, and institutional safety requirements.
